Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital.
- Author:
Sofia MARAKI
1
;
George SAMONIS
;
Dimitra DIMOPOULOU
;
Elpis MANTADAKIS
Author Information
- Publication Type:Brief Communication
- Keywords: Daptomycin; Glycopeptide-resistant enterococci; Linezolid; Quinupristin/dalfopristin; Teicoplanin; Tigecycline
- MeSH: Daptomycin*; Enterococcus faecalis; Enterococcus faecium; Linezolid; Teicoplanin
- From:Infection and Chemotherapy 2014;46(4):253-256
- CountryRepublic of Korea
- Language:English
- Abstract: We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while 17.1% (12/70) and 11.4% (8/70) were resistant to quinupristin/dalfopristin (QD) and tigecycline, respectively. All E. faecalis isolates were resistant to QD, while 4 of 62 (6.5%) E. faecium isolates were resistant to QD. All E. faecalis isolates were susceptible to tigecycline, while 14.5% (9/62) E. faecium isolates were resistant. Continued surveillance of GRE antibiotic susceptibilities is important for combating these multi-resistant nosocomial pathogens.
